After having acquired French-based AxPharma and US-based DS InPharmatics, PLG has continued teh expansion of its international footprint with the acquisition of ELC.
The Riverside Company, a global private investor focused on the smaller end of the middle market, has invested in eMindful, a provider of evidence-based, mindfulness programmes for everyday life and chronic conditions. The investment is an add-on to Riverside’s Wondr Health (formerly Naturally Slim), a digital behavioral change company focused
Coave Therapeutics, a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases, has raised an additional EUR21.2 million (USD25.1 million) of Series B funding, bringing the total raised to EUR33.1 million (USD39 million). This latest financing was led by
Aromyx, a specialist in applying biotechnology and data science to capture unique sensory data, has closed an oversubscribed USD10 million Series A round of financing led by Rabo Food&Ag Innovation Fund and SOZO Ventures. Existing investors Ulu Ventures, Radicle Growth, Capital Energy and Merus Capital also participated in the round.
LeapFrog Investments, a Profit with Purpose investment firm, has invested USD30 million in India’s leading health and wellness app, HealthifyMe. As the lead investor in a USD75 million Series C round, which includes Khosla Ventures and several existing investors, LeapFrog has acquired a significant minority stake in the healthtech company.
XPhyto Therapeutics Corp is to acquire 3a-diagnostics, Frickenhausen, Germany (3a), the company’s exclusive diagnostics development partner. Pursuant to the definitive agreement, XPhyto will acquire all of the outstanding shares of 3a for EUR400,000, to be paid immediately, and EUR3.5 million, to be paid on closing, planned for on or around
Vantage Health has been acquired by Northgate Public Services (NPS), a leading software and services provider to the public sector in the UK and a wholly owned subsidiary of NEC Corporation. NPS has a market leading screening software for diabetes and hearing. It has helped to screen 10 million babies
Calculus Capital (Calculus) and Foresight Group (Foresight), have sold Mologic Limited (Mologic), a specialist in lateral flow and rapid diagnostic technologies, and founder of Global Access Diagnostics. Mologic’s co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test, the world’s first commercial application of lateral
Private equity firm WestBridge has exited its investment in portfolio company AJM Healthcare following the company’s acquisition by Livingbridge. AJM provides wheelchair and mobility solutions to the NHS, Local Authorities and individuals across the UK. The transaction marks the first exit from the firm’s second fund and has been completed
Varagon Capital Partners, LP (Varagon) has announced it is serving as Administrative Agent, Lead Arranger and Bookrunner on a senior secured credit facility to support the rapid growth of Paradigm Oral Surgery (Paradigm), a portfolio company of InTandem Capital Partners (InTandem).
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
